Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04571762 | Adaptive MR-guided SBRT for Localized Prostate Cancer | unknown | N/A | 12 | University of ZurichOTHER | 0 | May 23, 2024 | clinicaltrials |
| NCT06227156 | Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | May 23, 2024 | clinicaltrials |
| NCT06427291 |
| Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients |
| unknown |
| Phase 1 |
| 20 |
| Fudan UniversityOTHER |
| 1 |
| May 23, 2024 |
| clinicaltrials |
| NCT05622162 | Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7(MIP7) | unknown | Phase 3 | 106 | ITEL Telecomunicazioni SrlINDUSTRY | 1 | May 22, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT06278610 | Pelvic Exenteration and Laterally Extended Pelvic Resection(Pre-PEX) | unknown | — | 85 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05024318 | NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma(NAPSTER) | unknown | Phase 2 | 20 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06416319 | Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)(PreAct) | unknown | N/A | 164 | Universitätsmedizin MannheimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT03141671 | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) | unknown | Phase 2 | 345 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05957822 | Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | unknown | Phase 4 | 148 | Konkuk University Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06402552 | Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy | unknown | N/A | 370 | Chang Gung Memorial HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT05385406 | HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid | unknown | N/A | 5,500 | Prof. Patrick PetignatOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06377267 | Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)(STROBE) | unknown | Phase 2 | 100 | Vall d'Hebron Institute of OncologyOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406322 | Pelvic Floor Dysfunction and Aerobic Training in Gynecological Cancer | unknown | N/A | 40 | Atılım UniversityOTHER | 0 | May 9, 2024 | clinicaltrials |
| NCT05354102 | A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 | unknown | Phase 1 | 11 | Biomica Ltd.INDUSTRY | 1 | May 7, 2024 | clinicaltrials |
| NCT00892866 | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | unknown | N/A | 877 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT01649089 | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | unknown | N/A | 224 | GOG FoundationNETWORK | 3 | May 3, 2024 | clinicaltrials |
| NCT06081686 | Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 32 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | May 3, 2024 | clinicaltrials |
| NCT04486781 | A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma | unknown | Phase 2 | 38 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT06394297 | VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC)(VIBE) | unknown | N/A | 30 | Fundacao ChampalimaudOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06391879 | Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma | unknown | — | 300 | Peking University First HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT05458544 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application(LUCIDA) | unknown | Phase 1 / Phase 2 | 26 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT05579184 | [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2(LUCIDA_2) | unknown | Phase 2 | 20 | FutureChemINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT06387238 | Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer | unknown | N/A | 150 | Peking University First HospitalOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT00831142 | Characterization of Prostate Cancer With 3T MR | unknown | — | 236 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06385847 | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | unknown | Phase 2 | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06305494 | Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors | unknown | — | 425 | Khon Kaen UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT03558048 | The Effect of IBD Flares on Serum PSA | unknown | — | 400 | Northwestern UniversityOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05989724 | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 150 | Qurgen Inc.INDUSTRY | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06253169 | HPV DNA Self-sampling in a General Practitioner's Office.(ASTRA) | unknown | — | 2,000 | Patient Organization VeronicaOTHER_GOV | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06378840 | the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer | unknown | — | 20 | RenJi HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06374914 | Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients | unknown | — | 120 | Dokuz Eylul UniversityOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06376604 | Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies | unknown | N/A | 30 | L-Nutra IncINDUSTRY | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06366308 | Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population | unknown | — | 10,000 | West China HospitalOTHER | 0 | Apr 16, 2024 | clinicaltrials |
| NCT03700099 | Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05748353 | Endocrine Disruptors and Life STILe in Breast Cancer Development(STILVARCA) | unknown | — | 275 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06308406 | A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer | unknown | Phase 1 / Phase 2 | 54 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 11, 2024 | clinicaltrials |
| NCT04387500 | Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma | unknown | Phase 2 | 41 | West China HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05848648 | PPK Study Based on Quantitative Pharmacology in Patients With Pamipril | unknown | — | 50 | Qianfoshan HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06355076 | New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection | unknown | N/A | 94 | Qilu Hospital of Shandong UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT05669443 | Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy | unknown | N/A | 42 | Gangnam Severance HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT06351228 | Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project(Eternity) | unknown | — | 400 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT02266745 | A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts | unknown | Phase 2 | 109 | Promontory Therapeutics Inc.INDUSTRY | 2 | Apr 5, 2024 | clinicaltrials |
| NCT05204199 | Role of Microbiome in BCG Responsiveness Prediction(SILENTEMPIRE) | unknown | — | 120 | Cédric PoyetOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06347614 | Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study(Two-step RP) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06344715 | Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC. | unknown | Phase 1 | 78 | SL VAXiGENINDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06241235 | Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma | unknown | Phase 1 / Phase 2 | 48 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06341855 | Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer | unknown | N/A | 100 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 2, 2024 | clinicaltrials |
Data updated 23 days agoSource updated May 23, 2024source: clinicaltrials